drugset / Trial / NCT01023776
Infectivity, Replication & Immunogenicity of Live nH1N1 Vaccine
NaSingle-groupOpen-labelPrevention
Summary
The purpose of the study is to determine the amount of live virus that can be recovered from the nose of people who are vaccinated with the licensed live vaccine against H1N1, and to describe the immune response to vaccination.
Timeline
- Start
- 2009-11
- Primary completion
- 2010-04
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | A/California/07/09 live monovalent H1N1 vaccine | Vaccine | 0.1 ml | Intranasal |